Helen of Troy (HELE) Q3 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 earnings summary
8 Jan, 2026Executive summary
Q3 FY2026 net sales declined 3.4% year-over-year to $512.8 million, with growth in Osprey, OXO, and Olive & June, and a 21% increase in organic DTC revenue.
Olive & June exceeded expectations, contributing $37.7 million in quarterly sales and positively impacting segment performance.
Net loss was $84.1 million for the quarter, primarily due to $65.9 million in non-cash asset impairment charges and higher tax expense.
Adjusted operating income and EPS declined sharply year-over-year, reflecting lower sales, higher tariffs, and increased costs.
Leadership is prioritizing operational efficiency, innovation, and a shift from cost-cutting to revenue growth.
Financial highlights
Q3 FY2026 net sales were $512.8 million, down 3.4% year-over-year; gross margin decreased to 46.9% from 48.9%.
Adjusted operating margin fell to 12.9% (down 370 bps); adjusted EBITDA margin was 14.7% (down 350 bps); adjusted EPS was $1.71, down from $2.67.
Net cash from operating activities for Q3 was $11.9 million; nine-month free cash flow was $28.8 million, down from $56.1 million.
Inventory increased to $505.3 million, including $35 million in higher tariff costs.
Total debt rose to $892.4 million, with $325 million in revolver availability.
Outlook and guidance
FY2026 net sales expected between $1.758 billion and $1.773 billion, down 7.1–7.8% year-over-year; Home & Outdoor $812–$819 million, Beauty & Wellness $946–$954 million.
Adjusted EPS guidance is $3.25–$3.75; GAAP diluted loss per share forecasted at $(36.07) to $(35.57).
Full-year GAAP SG&A ratio expected at 38%–40%; adjusted effective tax rate at 13.4%–14.7%.
Inventory projected at $475–$490 million at year-end, including $39 million in incremental tariff costs.
Margin pressure and revenue softness expected to persist due to tariffs, promotional environment, and delayed pricing realization.
Latest events from Helen of Troy
- Prioritizing high-growth brands, revenue focus, and global expansion to drive long-term value.HELE
28th Annual ICR Conference 20263 Feb 2026 - Sales and earnings fell sharply, prompting lower guidance and continued restructuring.HELE
Q1 20253 Feb 2026 - All proposals passed as the company focuses on brand revitalization and operational transformation.HELE
AGM 202423 Jan 2026 - Q2 sales and margins fell, but guidance, cash flow, and $500M buyback remain on track.HELE
Q2 202519 Jan 2026 - $240M acquisition of a high-growth nail brand, immediately accretive and diversifying the portfolio.HELE
M&A Announcement12 Jan 2026 - Sales fell 3.4% as Home & Outdoor grew and Beauty & Wellness declined; guidance narrowed.HELE
Q3 202510 Jan 2026 - Brand revitalization, strategic acquisition, and operational efficiency drive growth and margin gains.HELE
27th Annual ICR Conference 202510 Jan 2026 - Q4 sales and adjusted EPS declined, FY26 faces $200M+ tariff risk with 70–80% mitigation planned.HELE
Q4 202523 Dec 2025 - Shareholders to vote on board, compensation, new stock plan, and auditor amid growth strategy launch.HELE
Proxy Filing1 Dec 2025